CA-BOTANA INTERNATIONAL – FDA 483, Apr 4, 2025
CA BOTANA International, Inc. in San Diego, CA, an OTC drug manufacturer, received a Form 483 with five observations during an inspection from April 2-4, 2025. The inspection revealed significant issues with quality control, equipment qualification, laboratory controls, and component testing, many of which were repeated from a previous inspection. The firm failed to validate manufacturing processes, qualify equipment and water systems, investigate out-of-specification results, qualify contract testing laboratories, and test high-risk components like glycerin for impurities.
- Person
ID · 7df8886e-7e05-4f7a-9691-554a3cab829b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.